If you’ve ever picked up a Japanese skincare product and seen “quasi-drug” or “医药部外品” on the label, you’re not alone in wondering what it means. A Japanese quasi-drug is a regulatory category, defined under Japan’s Pharmaceutical and Medical Device Act, for products with government-approved active ingredients and a mild, prevention-focused effect — something that sits between an ordinary cosmetic and a full pharmaceutical drug. It is not simply a “stronger cosmetic,” and it is not a medicine in the way a prescription drug is.
What Is a Quasi-Drug in Japan?
Under Article 2, Paragraph 2 of Japan’s Pharmaceutical and Medical Device Act (PMD Act), a quasi-drug (医药部外品, iyakubugaihin) is a product with a mild effect on the human body, used for a specific approved purpose such as:
- Preventing nausea or other discomfort, bad breath, or body odor
- Preventing heat rash, chafing, or skin soreness
- Preventing hair loss, or promoting hair growth or hair removal
- Controlling pests such as rodents, flies, mosquitoes, or fleas for hygiene purposes
To be sold as a quasi-drug, a product must contain active ingredients that the Ministry of Health, Labour and Welfare (MHLW) has officially approved for that purpose, at a set concentration. The product then goes through a pre-market review by the Pharmaceuticals and Medical Devices Agency (PMDA) before it can be marketed. This is different from an ordinary cosmetic, which does not require this kind of pre-market approval in Japan.
In practice, quasi-drugs cover a wide range of everyday products: medicated skincare, antiperspirants, medicated toothpaste, hair dye, hair growth tonics, and hair removal products all fall into this category.
Drug vs Quasi-Drug vs Cosmetic: Quick Comparison
Japan’s system splits personal care and health products into three main tiers. Here’s how they compare at a glance.
| Drug (医药品) | Quasi-Drug (医药部外品) | Cosmetic (化粘品) | |
|---|---|---|---|
| Primary purpose | Diagnose, treat, or prevent disease | Prevent discomfort or support hygiene, with a mild effect | Beautify and maintain the condition of skin and hair |
| Active ingredients | Prescription or approved OTC actives | MHLW-approved active ingredients at set concentrations | No officially designated “active ingredients” |
| Pre-market approval | Required | Required (PMDA review) | Not required for most products |
| Permitted claims | Treatment, cure, disease-specific claims | Approved-ingredient efficacy claims, plus the standard cosmetic claims | A defined list of mild claims only (e.g. moisturizes, conditions skin texture) |
| Typical examples | Prescription medicine, many OTC drugs | Medicated whitening lotion, antiperspirant, hair growth tonic, medicated toothpaste, hair dye | Ordinary moisturizer, foundation, standard shampoo |
| Treatment vs. prevention | Treatment | Prevention / hygiene-oriented care | Care and beautification only |
What Is the Difference Between a Quasi-Drug and a Cosmetic?
The core difference comes down to active ingredients and what a product is legally allowed to claim. Japan maintains a list of 56 standard efficacy claims that any cosmetic can use, things like “moisturizes the skin” or “prevents dryness caused by external factors.” These claims are intentionally mild, and cosmetics cannot describe themselves as containing an “active ingredient” with a specific, government-recognized effect.
A quasi-drug, by contrast, can only use the word “active ingredient” (有効成分) because MHLW has reviewed and approved that specific ingredient, at a specific concentration, for a specific purpose in that product. A medicated whitening essence sold as a quasi-drug can claim to help prevent spots and freckles caused by sunburn through its approved active ingredient. An ordinary cosmetic serum, even one containing a similar-sounding ingredient, legally cannot make that same claim unless it too has gone through quasi-drug approval.
This is also why quasi-drug status is not really about “strength.” It’s about whether a specific formulation has gone through Japan’s approval process for a specific, defined effect.
What Is the Difference Between a Quasi-Drug and a Drug?
Quasi-drugs sit below full pharmaceuticals in both regulatory weight and intended use. A drug (医药品) in Japan is meant to diagnose, treat, cure, or prevent a disease, and many require a prescription or are sold as regulated over-the-counter drugs, often only through a pharmacy with a pharmacist present.
Quasi-drugs are explicitly framed around prevention and mild, non-disease-specific purposes, such as preventing rough skin or body odor, rather than treating an existing medical condition. Because their intended effect is milder and more narrowly defined, quasi-drugs can be sold far more widely than most drugs — in convenience stores, supermarkets, and drugstores, without a pharmacist needing to be present.
What Does “Medicated” Mean in Japanese Skincare?
“Medicated” is the standard English translation used for products labeled 薪用 (yakuyo) in Japanese. Only quasi-drugs are legally permitted to use this word. If you see “medicated lotion” or “medicated whitening essence” on a Japanese product, that product has gone through quasi-drug approval and contains at least one MHLW-approved active ingredient.
It’s worth being precise here rather than treating “medicated” as a marketing flourish: it is a regulatory signal, not a general claim of extra strength. A medicated product’s approved effect is specific to its approved active ingredient and purpose, for example, preventing acne caused by rough skin, and it’s not a blanket guarantee that the product outperforms every cosmetic on every measure.
What Do “Yakuyo” and “Iyakubugaihin” Mean?
These two Japanese terms are closely related but not identical, and both show up often on packaging and Japanese e-commerce sites.
医药部外品 (iyakubugaihin) is the formal regulatory category itself, quasi-drug. It’s the term you’ll see on the back of a package, often in small print, identifying the product’s legal classification.
薪用 (yakuyo), translated as “medicated,” is a marketing and labeling term that signals a product is a quasi-drug with an approved active ingredient. In practice, most yakuyo-labeled skincare products are quasi-drugs, since the term is legally restricted to that category. But not every quasi-drug uses the word yakuyo on its front label, some quasi-drug categories, like hair dye or insect repellents, are identified in other ways. When comparing products, the presence of 医药部外品 in the fine print is the more reliable indicator of quasi-drug status than the word yakuyo alone.
Common Examples of Japanese Quasi-Drug Skincare
Based on the categories defined under the PMD Act, quasi-drug skincare and personal care products typically fall into a few recognizable groups:
- Whitening and brightening care — medicated lotions, essences, and creams formulated with an MHLW-approved active ingredient to help prevent spots and freckles caused by sunburn
- Acne-prevention care — medicated products intended to help prevent skin roughness and acne linked to skin conditions
- Antiperspirants and deodorants — products intended to prevent body odor
- Hair growth tonics — scalp products intended to encourage hair growth or prevent hair loss
- Hair dye and hair removal products
- Medicated toothpaste — formulated to help prevent specific oral health issues
Whether a specific product on a specific shelf is a quasi-drug or an ordinary cosmetic depends on its individual approval, not just its product type, so the safest way to confirm is to check the packaging for 医药部外品 rather than assuming based on the product category alone.
Are Japanese Quasi-Drugs More Effective Than Cosmetics?
Not automatically, and this is one of the more common misunderstandings among overseas shoppers. Quasi-drug status confirms that a product’s specific active ingredient, at its approved concentration, has gone through MHLW review for a defined, narrow effect. It does not mean the finished product is universally “stronger” or better suited to every skin concern than every cosmetic.
A few distinctions matter here. Having an approved active ingredient is not the same as the ingredient being present at a clinically meaningful concentration for your specific skin. Evidence for an ingredient’s mechanism of action isn’t the same as evidence that a specific finished formulation, with its own texture, stability, and delivery system, produces a noticeable result on your skin. And a well-formulated cosmetic, without quasi-drug status, can still be an effective, well-designed product for its intended purpose.
The honest takeaway is that quasi-drug approval tells you something meaningful about a product’s regulatory status and its ingredient, but it isn’t a shortcut for evaluating whether that specific product is right for you.
How to Identify a Quasi-Drug on Japanese Packaging
The most reliable way to identify a quasi-drug is to look for the words 医药部外品 printed on the packaging, usually near the ingredient list or manufacturer information on the back or side of the product. This is a required disclosure, not optional marketing text.
Other signals that often, but not always, accompany quasi-drug status include the word 薪用 (yakuyo, “medicated”) on the front label, and a section listing “有効成分” (active ingredients) separately from “その他の成分” (other ingredients) in the ingredient list. This separation itself is a strong clue, since ordinary cosmetics in Japan don’t use the “active ingredient” heading.
Are Japanese Quasi-Drugs Treated the Same Way Overseas?
No, and this trips up a lot of shoppers comparing Japanese products to what they’re used to at home. Japan’s three-tier system of drug, quasi-drug, and cosmetic doesn’t map cleanly onto other regulatory systems.
In the United States, the FDA generally regulates products as either cosmetics or drugs, and a single product can be regulated as both at once if it makes drug-type claims (this is how many American sunscreens and anti-dandruff shampoos are classified, under the OTC drug monograph system). There isn’t a separate formal “quasi-drug” tier. In the European Union and United Kingdom, cosmetics are regulated under cosmetics-specific frameworks with restrictions on the claims a cosmetic can make, but there also isn’t a direct equivalent to Japan’s quasi-drug category. A product Japan classifies as a quasi-drug might be sold as an ordinary cosmetic, an OTC drug, or something in between elsewhere, depending on its ingredients and claims.
Because of this, a Japanese quasi-drug approval doesn’t carry over as a formal approval anywhere else. It reflects Japan’s own regulatory process and doesn’t imply, for example, FDA approval or equivalent status abroad.
FAQ
Is a quasi-drug a medicine?
Not in the way a prescription or OTC drug is. It’s a distinct, milder category focused on prevention and hygiene, defined under Japan’s PMD Act.
Is a quasi-drug better than a cosmetic?
Not automatically. It means the product has an MHLW-approved active ingredient for a specific purpose, not that it will outperform every cosmetic for every person.
What does “medicated” mean on a Japanese product?
It’s the common translation of 薪用 (yakuyo), a term legally restricted to quasi-drugs with an approved active ingredient.
What does “Yakuyo” mean?
Literally “for medicinal use.” On Japanese skincare, it signals quasi-drug status rather than describing a specific strength.
What does “Iyakubugaihin” mean?
It’s the Japanese term for the quasi-drug regulatory category itself, the formal classification printed on approved product packaging.
Are Japanese quasi-drugs safe?
Quasi-drugs go through MHLW/PMDA review before they can be sold, which covers their approved active ingredients and intended use. As with any skincare product, individual reactions vary, and patch-testing is worth doing with new products.
Can I buy Japanese quasi-drugs outside Japan?
Many are sold through international retailers and are legal to purchase and use as a consumer product, but their Japanese quasi-drug approval doesn’t equate to a formal regulatory approval in your own country.
Final Takeaway
A Japanese quasi-drug isn’t simply a “stronger cosmetic” or an over-the-counter medicine. It’s a specific regulatory category, built around MHLW-approved active ingredients and a narrowly defined, prevention-focused effect, that sits deliberately between ordinary cosmetics and full pharmaceuticals. Understanding that system, rather than relying on the word “medicated” alone, is what actually helps when you’re comparing Japanese skincare to products from anywhere else.
This article explains Japan’s quasi-drug system for general understanding and is not medical advice. See our Disclaimer and Editorial Policy for more on how we research and fact-check articles like this one.